Purple Biotech (PPBT) Change in Acquisitions & Divestments (2017 - 2023)
Purple Biotech (PPBT) reported Change in Acquisitions & Divestments of -$6000.0 for Q4 2023, down 100.03% year-over-year from $22.1 million in Q4 2022, and down 100.03% quarter-over-quarter from $22.1 million in Q4 2022.
Purple Biotech (PPBT) Change in Acquisitions & Divestments (2017 - 2023) Analysis & Trends
Purple Biotech (PPBT) has 4 years of Change in Acquisitions & Divestments data on file, last reported at -$6000.0 in Q4 2023.
- Change in Acquisitions & Divestments for Q4 2023 came in at -$6000.0, down 100.03% year-over-year; the trailing twelve-month figure through Dec 2023 was $31.2 million (changed N/A YoY), and the FY2025 annual result was -$9000.0, down 550.0% from the prior year.
- Change in Acquisitions & Divestments eased to -$6000.0 in Q4 2023 per PPBT's latest filing, from $22.1 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $22.1 million in Q4 2022 and troughed at -$6000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -6,000.00 |
| Dec 31, 2023 | -6,000.00 |
| Dec 31, 2022 | 22.14 Mn |
| Dec 31, 2022 | 22.14 Mn |
| Dec 31, 2018 | 5.03 Mn |
| Dec 31, 2018 | 5.03 Mn |
| Dec 31, 2017 | 4.05 Mn |
| Dec 31, 2017 | 4.05 Mn |